Kuss BJ - Search Results

1

Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia.

Allan JN, Flinn IW, Siddiqi T, Ghia P, Tam CS, Kipps TJ, Barr PM, Elinder Camburn A, Tedeschi A, Badoux XC, Jacobs R, Kuss BJ, Trentin L, Zhou C, Szoke A, Abbazio C, Wierda WG. Allan JN, et al. Among authors: kuss bj. Clin Cancer Res. 2023 Jul 14;29(14):2593-2601. doi: 10.1158/1078-0432.CCR-22-2779. Clin Cancer Res. 2023. PMID: 37282671 Free PMC article.

2

ARA, a novel ABC transporter, is located at 16p13.1, is deleted in inv(16) leukemias, and is shown to be expressed in primitive hematopoietic precursors.

Kuss BJ, O'Neill GM, Eyre H, Doggett NA, Callen DF, Davey RA. Kuss BJ, et al. Genomics. 1998 Aug 1;51(3):455-8. doi: 10.1006/geno.1998.5349. Genomics. 1998. PMID: 9721217

3

The perivertebral collar--a new sign in lymphoproliferative malignancies.

Albertyn LE, Croft G, Kuss B, Dale B. Albertyn LE, et al. Australas Radiol. 1992 Aug;36(3):214-8. doi: 10.1111/j.1440-1673.1992.tb03154.x. Australas Radiol. 1992. PMID: 1445104

4

Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications.

Kuss BJ, Deeley RG, Cole SP, Willman CL, Kopecky KJ, Wolman SR, Eyre HJ, Lane SA, Nancarrow JK, Whitmore SA, et al. Kuss BJ, et al. Lancet. 1994 Jun 18;343(8912):1531-4. doi: 10.1016/s0140-6736(94)92938-6. Lancet. 1994. PMID: 7911871

5

Identification of an inversion 16 coexisting with an isochromosome 22q by in situ hybridization in a case of childhood AML M4e.

Gad SG, Callen DF, Kuss B, Downing JR, Behm F, Head D, Ribeiro RC, Raimondi SC. Gad SG, et al. Leukemia. 1993 Oct;7(10):1658-62. Leukemia. 1993. PMID: 8412329

6

Cancer-targeting siRNA delivery from porous silicon nanoparticles.

Wan Y, Apostolou S, Dronov R, Kuss B, Voelcker NH. Wan Y, et al. Nanomedicine (Lond). 2014 Oct;9(15):2309-21. doi: 10.2217/nnm.14.12. Epub 2014 Mar 5. Nanomedicine (Lond). 2014. PMID: 24593001

7

The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias.

Kuss BJ, Deeley RG, Cole SP, Willman CL, Kopecky KJ, Wolman SR, Eyre HJ, Callen DF. Kuss BJ, et al. Leuk Lymphoma. 1996 Feb;20(5-6):357-64. doi: 10.3109/10428199609052416. Leuk Lymphoma. 1996. PMID: 8833390 Review.

8

Warming blood prior to transfusion using latent heat.

Roxby D, Sobieraj-Teague M, von Wielligh J, Sinha R, Kuss B, Smith AL, McEwen M. Roxby D, et al. Emerg Med Australas. 2020 Aug;32(4):604-610. doi: 10.1111/1742-6723.13471. Epub 2020 Feb 11. Emerg Med Australas. 2020. PMID: 32048424

9

Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles.

Hasanzadeh Kafshgari M, Alnakhli M, Delalat B, Apostolou S, Harding FJ, Mäkilä E, Salonen JJ, Kuss BJ, Voelcker NH. Hasanzadeh Kafshgari M, et al. Among authors: kuss bj. Biomater Sci. 2015 Dec;3(12):1555-65. doi: 10.1039/c5bm00204d. Epub 2015 Sep 7. Biomater Sci. 2015. PMID: 26343506

10

High dose hydroxyurea in collection of Philadelphia chromosome-negative stem cells in chronic myeloid leukaemia.

Kuss BJ, Sage RE, Shepherd KM, Hardingham J, Nicola M. Kuss BJ, et al. Leuk Lymphoma. 1993 May;10(1-2):73-8. doi: 10.3109/10428199309147359. Leuk Lymphoma. 1993. PMID: 8374526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters